// App-Quantinova.ai

: The Bristol Bladder Trial: Five year outcomes in patients treated with neoadjuvant cabazitaxel and cisplatin chemotherapy for muscle invasive transitional cell carcinoma of the urinary bladder.

Researchers

Presenter

  • Amarnath Challapalli

Principal Investigators

  • Paul White

  • Susan Masson

  • Emily Foulstone

  • Emily Renninson

  • Alicia Bravo

  • Sylvia Pearson

  • Narges Dailami

  • Raj Persad

  • Anthony Koupparis

  • Edward Rowe

  • Jon Oxley

  • Julian Kabala

  • Janice Ash-Miles

  • Amit Bahl

Medical Centers

  • University Hospitals Bristol NHS Foundation Trust, Wells Somerset, United Kingdom

  • North Bristol NHS Trust, Bristol, United Kingdom

  • University of the West of England, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Cabazitaxel

  • Cisplatin

Outcome

  • N/A

Study Design

  • Single Arm

Phase

  • II

Study Id's

  • NCT01616875

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved